Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.

Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB.

Ann Surg Oncol. 2019 Sep 19. doi: 10.1245/s10434-019-07726-9. [Epub ahead of print]

PMID:
31538286
2.

Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.

Livingston-Rosanoff D, Hanlon B, Marka N, Vande Walle K, Stankowski-Drengler T, Schumacher J, Greenberg CC, Neuman H, Wilke LG.

Breast J. 2019 Sep 12. doi: 10.1111/tbj.13625. [Epub ahead of print]

PMID:
31513322
3.

A Randomized Controlled Trial Evaluating the Impact of Pre-Consultation Information on Patients' Perception of Information Conveyed and Satisfaction with the Decision-Making Process.

Stankowski-Drengler TJ, Tucholka JL, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Hanlon B, Steiman J, Neuman HB.

Ann Surg Oncol. 2019 Oct;26(10):3275-3281. doi: 10.1245/s10434-019-07535-0. Epub 2019 Jul 24.

PMID:
31342375
4.

Does Tumor Size Predict Response to Neoadjuvant Chemotherapy in the Modern Era of Biologically Driven Treatment? A Nationwide Study of US Breast Cancer Patients.

Livingston-Rosanoff D, Schumacher J, Vande Walle K, Stankowski-Drengler T, Greenberg CC, Neuman H, Wilke LG.

Clin Breast Cancer. 2019 Jun 6. pii: S1526-8209(19)30303-9. doi: 10.1016/j.clbc.2019.05.014. [Epub ahead of print]

PMID:
31300338
5.

Postoperative complications in combined gynecologic, plastic, and breast surgery: An analysis from National Surgical Quality Improvement Program.

Tevis SE, Steiman JG, Neuman HB, Greenberg CC, Wilke LG.

Breast J. 2019 Jul 6. doi: 10.1111/tbj.13429. [Epub ahead of print]

PMID:
31280491
6.

Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study.

Burnside ES, Trentham-Dietz A, Shafer CM, Hampton JM, Alagoz O, Cox JR, Mischo E, Schrager SB, Wilke LG.

Radiology. 2019 Aug;292(2):321-328. doi: 10.1148/radiol.2019181651. Epub 2019 Jun 11.

7.

BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.

Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E.

Radiology. 2019 Jun;291(3):554-569. doi: 10.1148/radiol.2019181814. Epub 2019 Apr 30.

PMID:
31038410
8.

Got Milk? Design and Implementation of a Lactation Support Program for Surgeons.

Livingston-Rosanoff D, Shubeck SP, Kanters AE, Dossett LA, Minter RM, Wilke LG.

Ann Surg. 2019 Jul;270(1):31-32. doi: 10.1097/SLA.0000000000003269. No abstract available.

PMID:
30921050
9.

Integrating survivorship care planning in radiation oncology workflow.

Huenerberg KJ, Anderson BM, Tevaarwerk AJ, Neuman HB, Wilke LG, Seaborne LA, Sesto M.

J Community Support Oncol. 2018 Mar-Apr;16(2):e66-e71. doi: 10.12788/jcso.0392.

10.

Staged Breast Operations: The Nipple Delay as an Old and New Idea.

Wilke LG.

Ann Surg. 2018 Dec;268(6):e40. doi: 10.1097/SLA.0000000000003064. No abstract available.

PMID:
30308609
11.

Variation in coordination of care reported by breast cancer patients according to health literacy.

Mora-Pinzon MC, Chrischilles EA, Greenlee RT, Hoeth L, Hampton JM, Smith MA, McDowell BD, Wilke LG, Trentham-Dietz A.

Support Care Cancer. 2019 Mar;27(3):857-865. doi: 10.1007/s00520-018-4370-3. Epub 2018 Jul 31.

PMID:
30062586
12.

Should Reexcision Rates in Breast Cancer Care be a Quality Measure?

Chagpar AB, Wilke LG.

Ann Surg Oncol. 2018 Oct;25(10):2818-2822. doi: 10.1245/s10434-018-6576-5. Epub 2018 Jun 26. No abstract available.

PMID:
29947002
13.

Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database.

Taylor LJ, Steiman J, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB.

Ann Surg Oncol. 2018 Aug;25(8):2229-2234. doi: 10.1245/s10434-018-6495-5. Epub 2018 May 31.

14.

The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients.

Esbona K, Yi Y, Saha S, Yu M, Van Doorn RR, Conklin MW, Graham DS, Wisinski KB, Ponik SM, Eliceiri KW, Wilke LG, Keely PJ.

Am J Pathol. 2018 Mar;188(3):559-573. doi: 10.1016/j.ajpath.2017.10.025.

15.

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).

Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC.

AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.

16.

Breast cancer survivor's perspectives on the role different providers play in follow-up care.

Tucholka JL, Jacobson N, Steffens NM, Schumacher JR, Tevaarwerk AJ, Anderson B, Wilke LG, Greenberg CC, Neuman HB.

Support Care Cancer. 2018 Jun;26(6):2015-2022. doi: 10.1007/s00520-018-4042-3. Epub 2018 Jan 13.

17.

A Randomized Controlled Trial Evaluating the Impact of Web-Based Information on Breast Cancer Patients' Knowledge of Surgical Treatment Options.

Tucholka JL, Yang DY, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Steiman J, Neuman HB.

J Am Coll Surg. 2018 Feb;226(2):126-133. doi: 10.1016/j.jamcollsurg.2017.10.024. Epub 2017 Dec 12.

18.

Cancer Survivorship Care Plan Utilization and Impact on Clinical Decision-Making at Point-of-Care Visits with Primary Care: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.

Donohue S, Haine JE, Li Z, Feldstein DA, Micek M, Trowbridge ER, Kamnetz SA, Sosman JM, Wilke LG, Sesto ME, Tevaarwerk AJ.

J Cancer Educ. 2019 Apr;34(2):252-258. doi: 10.1007/s13187-017-1295-3.

PMID:
29098650
19.

The Impact of a Primary Care Education Program Regarding Cancer Survivorship Care Plans: Results from an Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.

Donohue S, Haine JE, Li Z, Trowbridge ER, Kamnetz SA, Feldstein DA, Sosman JM, Wilke LG, Sesto ME, Tevaarwerk AJ.

J Cancer Educ. 2019 Feb;34(1):154-160. doi: 10.1007/s13187-017-1281-9.

PMID:
28932992
20.

Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors.

Schumacher JR, Taylor LJ, Tucholka JL, Poore S, Eggen A, Steiman J, Wilke LG, Greenberg CC, Neuman HB.

Ann Surg Oncol. 2017 Oct;24(10):3017-3023. doi: 10.1245/s10434-017-5933-0. Epub 2017 Aug 1.

21.

Mammography Screening: Gaps in Patient's and Physician's Needs for Shared Decision-Making.

DuBenske LL, Schrager S, McDowell H, Wilke LG, Trentham-Dietz A, Burnside ES.

Breast J. 2017 Mar;23(2):210-214. doi: 10.1111/tbj.12779. Epub 2017 Mar 2.

22.

Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.

Landercasper J, Bennie B, Parsons BM, Dietrich LL, Greenberg CC, Wilke LG, Linebarger JH.

Ann Surg Oncol. 2017 Jun;24(6):1507-1515. doi: 10.1245/s10434-016-5760-8. Epub 2017 Jan 6.

23.

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2017 Feb;24(2):375-397. doi: 10.1245/s10434-016-5688-z. Epub 2016 Dec 8. Review.

PMID:
27933411
24.

Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO "No Ink on Tumor" Guidelines.

Schulman AM, Mirrielees JA, Leverson G, Landercasper J, Greenberg C, Wilke LG.

Ann Surg Oncol. 2017 Jan;24(1):52-58. doi: 10.1245/s10434-016-5516-5. Epub 2016 Aug 31.

PMID:
27581607
25.

Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.

Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Margenthaler JA, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA.

Ann Surg Oncol. 2016 Oct;23(10):3106-11. doi: 10.1245/s10434-016-5408-8. Epub 2016 Jul 28. No abstract available.

26.

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.

Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, Greenberg CC, Kass RB, Landercasper J, Lemaine V, MacNeill F, Song DH, Staley AC, Wilke LG, Willey SC, Yao KA, Margenthaler JA.

Ann Surg Oncol. 2016 Oct;23(10):3100-5. doi: 10.1245/s10434-016-5443-5. Epub 2016 Jul 28. No abstract available.

27.

Oncologists' perceived barriers to an expanded role for primary care in breast cancer survivorship care.

Neuman HB, Jacobs EA, Steffens NM, Jacobson N, Tevaarwerk A, Wilke LG, Tucholka J, Greenberg CC.

Cancer Med. 2016 Sep;5(9):2198-204. doi: 10.1002/cam4.793. Epub 2016 Jun 30.

28.

Current Trends in the Management of Phyllodes Tumors of the Breast.

Adesoye T, Neuman HB, Wilke LG, Schumacher JR, Steiman J, Greenberg CC.

Ann Surg Oncol. 2016 Oct;23(10):3199-205. doi: 10.1245/s10434-016-5314-0. Epub 2016 Jun 22.

29.

The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.

Decker MR, Trentham-Dietz A, Loconte NK, Neuman HB, Smith MA, Punglia RS, Greenberg CC, Wilke LG.

Ann Surg Oncol. 2016 Sep;23(9):2788-94. doi: 10.1245/s10434-016-5192-5. Epub 2016 Mar 29.

30.

Dissemination and implementation: Translating cancer guidelines and clinical trial outcomes into everyday practice.

Wilke LG, Dickson-Witmer D, Boughey JC.

Bull Am Coll Surg. 2016 Feb;101(2):33-4. No abstract available.

PMID:
26995861
31.

Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals V╬┤2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate.

Zumwalde NA, Haag JD, Sharma D, Mirrielees JA, Wilke LG, Gould MN, Gumperz JE.

Cancer Prev Res (Phila). 2016 Apr;9(4):305-16. doi: 10.1158/1940-6207.CAPR-15-0370-T. Epub 2016 Jan 25.

32.

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).

Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK.

Ann Surg. 2016 Apr;263(4):802-7. doi: 10.1097/SLA.0000000000001375.

33.

Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates, and Clinicians.

Mirrielees JA, Breckheimer KR, White TA, Denure DA, Schroeder MM, Gaines ME, Wilke LG, Tevaarwerk AJ.

J Cancer Educ. 2017 Mar;32(1):97-104. doi: 10.1007/s13187-015-0932-y.

34.

Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.

Neuman HB, Steffens NM, Jacobson N, Tevaarwerk A, Anderson B, Wilke LG, Greenberg CC.

Ann Surg Oncol. 2016 Mar;23(3):708-14. doi: 10.1245/s10434-015-4904-6. Epub 2015 Oct 16.

35.

Correction: differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumors.

Shlensky D, Mirrielees JA, Zhao Z, Wang L, Mahajan A, Yu M, Sherer NM, Wilke LG, Xu W.

PLoS One. 2015 Jun 25;10(6):e0131955. doi: 10.1371/journal.pone.0131955. eCollection 2015. No abstract available.

36.

A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins.

Nichols BS, Schindler CE, Brown JQ, Wilke LG, Mulvey CS, Krieger MS, Gallagher J, Geradts J, Greenup RA, Von Windheim JA, Ramanujam N.

PLoS One. 2015 Jun 15;10(6):e0127525. doi: 10.1371/journal.pone.0127525. eCollection 2015.

37.

Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.

Shlensky D, Mirrielees JA, Zhao Z, Wang L, Mahajan A, Yu M, Sherer NM, Wilke LG, Xu W.

PLoS One. 2015 Jun 1;10(6):e0128143. doi: 10.1371/journal.pone.0128143. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131955.

38.

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton TS, Kuerer HM, Bowling M, Hunt KK; Alliance for Clinical Trials in Oncology.

Ann Surg. 2015 Mar;261(3):547-52. doi: 10.1097/SLA.0000000000000551.

39.

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).

Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HT.

J Clin Oncol. 2015 Oct 20;33(30):3386-93. doi: 10.1200/JCO.2014.57.8401. Epub 2015 Feb 2.

40.

Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010.

Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, Yao K.

JAMA Surg. 2014 Dec;149(12):1296-305. doi: 10.1001/jamasurg.2014.926.

PMID:
25390819
41.

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.

Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton T, Hunt KK.

Ann Surg. 2014 Oct;260(4):608-14; discussion 614-6. doi: 10.1097/SLA.0000000000000924.

42.

Commentary on the Canadian National Breast Screening study.

Van Zee KJ, Hansen NM, Barrio AV, Connor CS, Danforth DN, Euhus DM, Kulkarni SA, McCready DR, McLaughlin S, Wilke LG.

Ann Surg Oncol. 2014 Dec;21(13):4397-8. doi: 10.1245/s10434-014-3789-0. Epub 2014 May 24.

PMID:
24859935
43.

Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles.

Zasadil LM, Andersen KA, Yeum D, Rocque GB, Wilke LG, Tevaarwerk AJ, Raines RT, Burkard ME, Weaver BA.

Sci Transl Med. 2014 Mar 26;6(229):229ra43. doi: 10.1126/scitranslmed.3007965.

44.

Metastasis of primary lung carcinoma to the breast: a systematic review of the literature.

Mirrielees JA, Kapur JH, Szalkucki LM, Harter JM, Salkowski LR, Strigel RM, Traynor AM, Wilke LG.

J Surg Res. 2014 May 15;188(2):419-31. doi: 10.1016/j.jss.2014.01.024. Epub 2014 Jan 24. Review.

PMID:
24560348
45.

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK; Alliance for Clinical Trials in Oncology.

JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.

46.

Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.

Caretta-Weyer H, Greenberg CG, Wilke LG, Weiss J, LoConte NK, Decker M, Steffens NM, Smith MA, Neuman HB.

Ann Surg Oncol. 2013 Dec;20(13):4145-52. doi: 10.1245/s10434-013-3193-1.

47.

Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.

Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, Ray KA, Herndon JE 2nd, Coan A, Gutierrez A, Hornsby KP, Hamilton E, Wilke LG, Kimmick GG, Peppercorn JM, Jones LW.

Acta Oncol. 2014 Jan;53(1):65-74. doi: 10.3109/0284186X.2013.781673. Epub 2013 Aug 19.

PMID:
23957716
48.

Optical spectral surveillance of breast tissue landscapes for detection of residual disease in breast tumor margins.

Brown JQ, Bydlon TM, Kennedy SA, Caldwell ML, Gallagher JE, Junker M, Wilke LG, Barry WT, Geradts J, Ramanujam N.

PLoS One. 2013 Jul 26;8(7):e69906. doi: 10.1371/journal.pone.0069906. Print 2013.

49.

Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

Jones LW, Fels DR, West M, Allen JD, Broadwater G, Barry WT, Wilke LG, Masko E, Douglas PS, Dash RC, Povsic TJ, Peppercorn J, Marcom PK, Blackwell KL, Kimmick G, Turkington TG, Dewhirst MW.

Cancer Prev Res (Phila). 2013 Sep;6(9):925-37. doi: 10.1158/1940-6207.CAPR-12-0416. Epub 2013 Jul 10.

50.

Advancing optical imaging for breast margin assessment: an analysis of excisional time, cautery, and patent blue dye on underlying sources of contrast.

Bydlon TM, Barry WT, Kennedy SA, Brown JQ, Gallagher JE, Wilke LG, Geradts J, Ramanujam N.

PLoS One. 2012;7(12):e51418. doi: 10.1371/journal.pone.0051418. Epub 2012 Dec 10.

Supplemental Content

Loading ...
Support Center